Last reviewed · How we verify
BAL0891
At a glance
| Generic name | BAL0891 |
|---|---|
| Also known as | TTK-CS-101 |
| Sponsor | SillaJen, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BAL0891 CI brief — competitive landscape report
- BAL0891 updates RSS · CI watch RSS
- SillaJen, Inc. portfolio CI